6578
達邦蛋白
+0.05 (+0.29%)17.5522成交張數–本益比1.25股價淨值比2.28%殖利率2026-09-11資料日期
毛利率、營業利益率、淨利率
單季;近十年
單季營收
億元
| 季度 | 營收(億) | 營收年增 | 毛利(億) | 毛利率 | 營業利益(億) | 營業利益率 | 淨利率 |
|---|---|---|---|---|---|---|---|
| 2026Q2 | 1.1 | 18.3% | 0.3 | 26.1% | 0.1 | 9.4% | 8.6% |
| 2026Q1 | 0.8 | 19.7% | 0.2 | 21.9% | 0.0 | 0.9% | 6.8% |
| 2025Q4 | 0.8 | -0.9% | 0.2 | 23.5% | -0.1 | -13.9% | -54.8% |
| 2025Q3 | 0.7 | 21.1% | 0.2 | 22.9% | -0.2 | -30.6% | -17.9% |
| 2025Q2 | 0.9 | -7.3% | 0.2 | 21.1% | 0.0 | 4.8% | -16.3% |
| 2025Q1 | 0.7 | -32.2% | 0.2 | 21.9% | -0.0 | -0.4% | 3.1% |
| 2024Q4 | 0.8 | -18.8% | 0.2 | 21.2% | -0.0 | -0.5% | 1.3% |
| 2024Q3 | 0.6 | -34.6% | 0.1 | 18.6% | -0.0 | -7.4% | -2.6% |
| 2024Q2 | 1.0 | 0.6% | 0.2 | 23.0% | 0.0 | 3.5% | 5.3% |
| 2024Q1 | 1.0 | 1.9% | 0.2 | 18.1% | -0.0 | -0.6% | 6.8% |
| 2023Q4 | 1.0 | -12.5% | 0.2 | 20.9% | 0.1 | 5.0% | -3.3% |
| 2023Q3 | 0.9 | -0.1% | 0.1 | 11.3% | -0.1 | -14.0% | -34.0% |
| 2023Q2 | 1.0 | -16.1% | 0.1 | 11.5% | -0.1 | -8.6% | -10.9% |
| 2023Q1 | 1.0 | -13.9% | 0.0 | 4.4% | -0.1 | -14.4% | -13.5% |
| 2022Q4 | 1.2 | -9.3% | 0.1 | 8.3% | -0.1 | -7.4% | -10.5% |
| 2022Q3 | 0.9 | -18.7% | 0.1 | 5.8% | -0.1 | -15.9% | -7.7% |
| 2022Q2 | 1.2 | 7.5% | 0.0 | 3.4% | -0.2 | -15.1% | -13.1% |
| 2022Q1 | 1.2 | -10.4% | 0.0 | 0.6% | -0.2 | -19.5% | -9.3% |
| 2021Q4 | 1.3 | -32.4% | 0.1 | 4.6% | -0.1 | -11.5% | -10.2% |
| 2021Q3 | 1.1 | -31.1% | 0.1 | 5.6% | -0.1 | -13.7% | -12.7% |
| 2021Q2 | 1.1 | -29.9% | 0.1 | 10.8% | -0.1 | -6.5% | -8.2% |
| 2021Q1 | 1.3 | 19.2% | -0.0 | -1.4% | -0.3 | -21.3% | -21.0% |
| 2020Q4 | 1.9 | 48.9% | 0.3 | 14.5% | 0.0 | 0.9% | 0.5% |
| 2020Q3 | 1.6 | -14.6% | 0.3 | 20.4% | 0.1 | 5.2% | 5.4% |
| 2020Q2 | 1.5 | -17.7% | 0.3 | 17.6% | 0.1 | 6.6% | 2.3% |
| 2020Q1 | 1.1 | -28.6% | 0.1 | 12.3% | -0.0 | -4.2% | -5.3% |
| 2019Q4 | 1.3 | – | 0.2 | 14.0% | 0.0 | 0.3% | -2.7% |
| 2019Q3 | 1.8 | – | 0.4 | 21.1% | 0.1 | 7.0% | 2.5% |
| 2019Q2 | 1.9 | – | 0.4 | 22.7% | 0.2 | 9.0% | 5.7% |
| 2019Q1 | 1.5 | – | 0.3 | 20.6% | 0.1 | 6.1% | 6.2% |